Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT).

Armstrong TS, Mendoza T, Gning I, Coco C, Cohen MZ, Eriksen L, Hsu MA, Gilbert MR, Cleeland C.

J Neurooncol. 2006 Oct;80(1):27-35. Epub 2006 Apr 6. Erratum in: J Neurooncol. 2006 Oct;80(1):37. Gring, T [corrected to Gning, I].

PMID:
16598415
2.

Clinical utility of the MDASI-BT in patients with brain metastases.

Armstrong TS, Gning I, Mendoza TR, Weinberg JS, Gilbert MR, Tortorice ML, Cleeland CS.

J Pain Symptom Manage. 2009 Mar;37(3):331-40. doi: 10.1016/j.jpainsymman.2008.02.011. Epub 2008 Aug 3.

PMID:
18676120
3.

Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.

Armstrong TS, Gning I, Mendoza TR, Vera-Bolanos E, Gilbert MR, Rhines LD, Weinberg JS, Sanchez-Williams G, Levin V, Burton AW, Cleeland C.

J Neurosurg Spine. 2010 Apr;12(4):421-30. doi: 10.3171/2009.10.SPINE0943.

PMID:
20367379
4.

Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).

Wang XS, Williams LA, Eng C, Mendoza TR, Shah NA, Kirkendoll KJ, Shah PK, Trask PC, Palos GR, Cleeland CS.

Cancer. 2010 Apr 15;116(8):2053-63. doi: 10.1002/cncr.24920.

5.

Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory.

Gning I, Trask PC, Mendoza TR, Harle MT, Gutierrez KA, Kitaka SA, Sherman SI, Cleeland CS.

Oncology. 2009;76(1):59-68. doi: 10.1159/000178809. Epub 2008 Dec 1.

PMID:
19052478
6.

Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients.

Lin CC, Chang AP, Cleeland CS, Mendoza TR, Wang XS.

J Pain Symptom Manage. 2007 Feb;33(2):180-8.

PMID:
17280923
7.

Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.

Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, Weber RS, Lewin JS, Garden AS, Ang KK, S Wang X, Cleeland CS.

Head Neck. 2007 Oct;29(10):923-31.

PMID:
17358040
8.

Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients.

Wang XS, Laudico AV, Guo H, Mendoza TR, Matsuda ML, Yosuico VD, Fragante EP, Cleeland CS.

J Pain Symptom Manage. 2006 Jun;31(6):542-52.

PMID:
16793494
9.

Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer.

Nejmi M, Wang XS, Mendoza TR, Gning I, Cleeland CS.

J Pain Symptom Manage. 2010 Jul;40(1):75-86. doi: 10.1016/j.jpainsymman.2009.12.007.

PMID:
20619213
10.

Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory.

Ivanova MO, Ionova TI, Kalyadina SA, Uspenskaya OS, Kishtovich AV, Guo H, Mendoza TR, Novik A, Cleeland CS, Wang XS.

J Pain Symptom Manage. 2005 Nov;30(5):443-53.

PMID:
16310618
11.

Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients.

Wang XS, Wang Y, Guo H, Mendoza TR, Hao XS, Cleeland CS.

Cancer. 2004 Oct 15;101(8):1890-901.

12.

Risk factors for fatigue severity in primary brain tumor patients.

Armstrong TS, Cron SG, Bolanos EV, Gilbert MR, Kang DH.

Cancer. 2010 Jun 1;116(11):2707-15. doi: 10.1002/cncr.25018.

13.

The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis.

Rosenthal DI, Mendoza TR, Chambers MS, Burkett VS, Garden AS, Hessell AC, Lewin JS, Ang KK, Kies MS, Gning I, Wang XS, Cleeland CS.

Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1355-61. doi: 10.1016/j.ijrobp.2008.02.072. Epub 2008 May 22.

PMID:
18501527
14.

Japanese version of the MD Anderson Symptom Inventory: a validation study.

Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y.

J Pain Symptom Manage. 2003 Dec;26(6):1093-104.

PMID:
14654261
15.

Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure.

Fadol A, Mendoza T, Gning I, Kernicki J, Symes L, Cleeland CS, Lenihan D.

J Card Fail. 2008 Aug;14(6):497-507. doi: 10.1016/j.cardfail.2008.01.012. Epub 2008 May 27.

PMID:
18672198
16.

The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients.

Armstrong TS, Vera-Bolanos E, Gning I, Acquaye A, Gilbert MR, Cleeland C, Mendoza T.

Cancer. 2011 Jul 15;117(14):3222-8. doi: 10.1002/cncr.25892. Epub 2011 Jan 24.

17.

Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory.

Guirimand F, Buyck JF, Lauwers-Allot E, Revnik J, Kerguen T, Aegerter P, Brasseur L, Cleeland CS.

J Pain Symptom Manage. 2010 Apr;39(4):721-33. doi: 10.1016/j.jpainsymman.2009.08.014.

PMID:
20413059
18.

Assessing cancer symptoms in adolescents with cancer using the Taiwanese version of the M. D. Anderson Symptom Inventory.

Tseng TH, Cleeland CS, Wang XS, Lin CC.

Cancer Nurs. 2008 May-Jun;31(3):E9-16. doi: 10.1097/01.NCC.0000305728.50098.51.

PMID:
18453871
19.

Validation of the Mishel's uncertainty in illness scale-brain tumor form (MUIS-BT).

Lin L, Acquaye AA, Vera-Bolanos E, Cahill JE, Gilbert MR, Armstrong TS.

J Neurooncol. 2012 Nov;110(2):293-300. doi: 10.1007/s11060-012-0971-8. Epub 2012 Sep 11.

PMID:
22965831
20.

Greek M.D. Anderson Symptom Inventory: validation and utility in cancer patients.

Mystakidou K, Cleeland C, Tsilika E, Katsouda E, Primikiri A, Parpa E, Vlahos L, Mendoza T.

Oncology. 2004;67(3-4):203-10.

PMID:
15557779

Supplemental Content

Support Center